9182923

Source:http://linkedlifedata.com/resource/pubmed/id/9182923

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0035435, umls-concept:C0245662, umls-concept:C0253023, umls-concept:C1539477, umls-concept:C1705955, umls-concept:C1749467
pubmed:issue	6
pubmed:dateCreated	1997-6-26
pubmed:abstractText	To assess levels of soluble Fas (sFas) and soluble Fas ligand (sFas-L) in sera from patients with various rheumatic diseases: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), polymyositis/dermatomyositis (PM/DM), mixed connective tissue disease (MCTD), and Sjogren's syndrome (SS).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/9182923-9506592
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370605
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95, http://linkedlifedata.com/resource/pubmed/chemical/FASLG protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0004-3591
pubmed:author	pubmed-author:HasimotoHH, pubmed-author:KayagakiNN, pubmed-author:NozawaKK, pubmed-author:OkumuraKK, pubmed-author:TokanoYY, pubmed-author:YagitaHH
pubmed:issnType	Print
pubmed:volume	40
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1126-9
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9182923-Adolescent, pubmed-meshheading:9182923-Adult, pubmed-meshheading:9182923-Aged, pubmed-meshheading:9182923-Antigens, CD95, pubmed-meshheading:9182923-Arthritis, Rheumatoid, pubmed-meshheading:9182923-Child, pubmed-meshheading:9182923-Dermatomyositis, pubmed-meshheading:9182923-Fas Ligand Protein, pubmed-meshheading:9182923-Female, pubmed-meshheading:9182923-Humans, pubmed-meshheading:9182923-Lupus Erythematosus, Systemic, pubmed-meshheading:9182923-Male, pubmed-meshheading:9182923-Membrane Glycoproteins, pubmed-meshheading:9182923-Middle Aged, pubmed-meshheading:9182923-Mixed Connective Tissue Disease, pubmed-meshheading:9182923-Polymyositis, pubmed-meshheading:9182923-Reference Values, pubmed-meshheading:9182923-Rheumatic Diseases, pubmed-meshheading:9182923-Sjogren's Syndrome, pubmed-meshheading:9182923-Solubility
pubmed:year	1997
pubmed:articleTitle	Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases.
pubmed:affiliation	School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.
pubmed:publicationType	Journal Article